Schedule I · possession unlawful
New York lists psilocybin and psilocin in Schedule I. Knowing and unlawful possession remains a criminal offense.
NY legal and access quick reference
Reviewed on September 30, 2026 by iMD teamPsilocybin law and access in New York
A concise, source-dated explanation of statewide law, regulated access, and the difference between state and local policy.
Laws and implementation can change quickly. This page is educational information, not legal advice.
No enacted public access program
New York has no enacted personal-use, retail, dispensary, medical-psilocybin, or supervised-service program.
2026 medical proposals · active clinical research
New York lawmakers amended medical and pilot proposals in 2026, including a proposed medical psilocybin framework and a veteran/first-responder pilot with dedicated funding. Separately, major New York academic medical centers continue active psilocybin clinical research. These developments do not yet create a statewide public access program.
2026 New York psilocybin policy and research update
New York continued to develop several psilocybin policy proposals in 2026. A2142A/S5303A, the proposed Medical Psilocybin Act, was amended and recommitted to the Health Committees on May 8, 2026. The proposal would establish a medical-use framework for qualifying conditions under Department of Health oversight.
A separate proposal, S1801A/A3845A, would create a federally compliant psilocybin-assisted therapy pilot for veterans, first responders and other specified participants. The amended Senate version includes a dedicated pilot-program fund and a $5 million appropriation. Both proposals remain pending and are not current law.
New York also remains an active center for clinical research. Mount Sinai is recruiting for a Phase 2 study of psilocybin in major depressive disorder, while NYU Langone researchers continue psilocybin studies involving advanced-cancer distress and healthy older adults.
What local policy means
For Albany, Brooklyn, Buffalo, New York City, Rochester, Syracuse, White Plains and Yonkers, this New York page is the appropriate quick-reference starting point because no separate municipal action was retained as a distinct local-policy guide. Local rules can change, so verify current official records.
Cities covered by the New York guide
The statewide explanation above covers Albany, Brooklyn, Buffalo, New York City, Rochester, Syracuse, White Plains and Yonkers. A separate page appears below only where a documented municipal action adds material local context.
AlbanyCovered in New York guide
BrooklynCovered in New York guide
BuffaloCovered in New York guide
New York CityCovered in New York guide
RochesterCovered in New York guide
SyracuseCovered in New York guide
White PlainsCovered in New York guide
YonkersCovered in New York guide
Sources used for this review
This page was checked against the controlling state statutes, enacted laws, agency records, and official bill histories listed below.
- New York Public Health Law §3306 — controlled schedules ↗
- New York Penal Law §220.03 — possession ↗
- New York Assembly Bill A2142A — proposed Medical Psilocybin Act ↗
- New York Assembly Bill A3845A — proposed pilot program ↗
- New York Assembly Bill A628 — proposed adult natural psychedelics law ↗
- New York Senate: S5303A Medical Psilocybin Act ↗
- New York Senate: S1801A psilocybin-assisted therapy pilot ↗
- Mount Sinai: recruiting Phase 2 psilocybin study for major depressive disorder ↗
- NYU Langone: current psilocybin clinical research ↗
Common questions
Is psilocybin legal in New York?
No. Psilocybin and psilocin remain Schedule I substances, and knowing unlawful possession remains a criminal offense.
Does New York have a regulated psilocybin access program?
No. Medical, pilot, and adult-use bills remain proposals. They do not create current possession, retail, dispensary, medical, or service-center access.
Do city policies change New York law?
No. A local enforcement-priority policy may affect municipal enforcement, but it does not legalize commercial sale, create statewide legality, or override federal law.
What changed in New York psilocybin policy in 2026?
New York amended medical-psilocybin and veteran/first-responder pilot proposals in 2026. S5303A/A2142A would establish a medical psilocybin framework, while S1801A/A3845A would create a federally compliant pilot with dedicated funding. Neither proposal has been enacted.
Is psilocybin research active in New York in 2026?
Yes. New York academic medical centers continue psilocybin clinical research, including a recruiting Phase 2 major-depressive-disorder study at Mount Sinai and active psilocybin research programs at NYU Langone.
Continue at the right depth
The product-site link provides product-format and business-policy information. It does not change the law described on this page or establish legal access in any jurisdiction.